touchPODCAST

touchMDT – A comprehensive approach to symptom care in PBC – Discussion 3 - touchENDOCRINOLOGY

touchMDT for touchENDOCRINOLOGY

Listen to experts Prof. Sonja Ständer, Ms Michelle Clayton, Prof. Gideon Hirschfield and patient advocate, Mrs Collette Thain MBE, discuss individualizing management strategies for patients with cholestatic pruritus and primary biliary cholangitis (PBC), and the importance of patient education and counselling.

The multidisciplinary team and patient advocate:

Dermatologist – Prof. Sonja Ständer
University of Münster, Münster, Germany

Nurse – Ms Michelle Clayton
St James’ University Hospital, Leeds, UK

Hepatologist – Prof. Gideon Hirschfield
University of Toronto, Toronto, Canada 

Patient Advocate – Mrs Collette Thain MBE
PBC Foundation, Edinburgh, UK

This touchPODCAST is for HCPs outside of the UK and USA only.

This activity is funded by an independent medical education grant from GlaxoSmithKline Research & Development Ltd. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC^® accredited provider.

For further information visit our website: https://touchendocrinologyIME.org/mdt-cholestatic-pruritus-in-patients-with-pbc/

touchMDT – Symptom assessment and monitoring in clinical practice – Discussion 2 - touchENDOCRINOLOGY

touchMDT for touchENDOCRINOLOGY

Listen to experts Ms Michelle Clayton, Prof. Sonja Ständer and Prof. Gideon Hirschfield discuss the importance of assessing for cholestatic pruritus in patients with primary biliary cholangitis (PBC) and review the tools used in clinical practice.

The multidisciplinary team:

Nurse – Ms Michelle Clayton
St James’ University Hospital, Leeds, UK

Dermatologist – Prof. Sonja Ständer
University of Münster, Münster, Germany

Hepatologist – Prof. Gideon Hirschfield
University of Toronto, Toronto, Canada

This touchPODCAST is for HCPs outside of the UK and USA only.

This activity is funded by an independent medical education grant from GlaxoSmithKline Research & Development Ltd. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC^® accredited provider.

For further information visit our website: https://touchendocrinologyime.org/mdt-cholestatic-pruritus-in-patients-with-pbc/

touchMDT – Pruritus in PBC and me: The patient experience – Discussion 1 - touchENDOCRINOLOGY

touchMDT for touchENDOCRINOLOGY

Pruritus in PBC and me: The patient experience

Listen to experts Prof. Gideon Hirschfield and Prof. Sonja Ständer, plus patient advocate Mrs Collette Thain MBE, explore the burden of cholestatic pruritus in patients with primary biliary cholangitis (PBC).

The multidisciplinary team and patient advocate:

Hepatologist – Prof. Gideon Hirschfield
University of Toronto, Toronto, Canada

Dermatologist – Prof. Sonja Ständer
University of Münster, Münster, Germany 

Patient Advocate – Mrs Collette Thain MBE
PBC Foundation, Edinburgh, UK

This touchPODCAST is for HCPs outside of the UK and USA only.

This activity is funded by an independent medical education grant from GlaxoSmithKline Research & Development Ltd. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC^® accredited provider.

For further information visit our website: https://touchendocrinologyime.org/mdt-cholestatic-pruritus-in-patients-with-pbc/

touchMDT – Pruritus in PBC and me: The patient experience – Discussion 1 - touchDERMATOLOGY

touchMDT for touchDERMATOLOGY

Pruritus in PBC and me: The patient experience

Listen to experts Prof. Gideon Hirschfield and Prof. Sonja Ständer, plus patient advocate Mrs Collette Thain MBE, explore the burden of cholestatic pruritus in patients with primary biliary cholangitis (PBC).

The multidisciplinary team and patient advocate:

Hepatologist – Prof. Gideon Hirschfield
University of Toronto, Toronto, Canada

Dermatologist – Prof. Sonja Ständer
University of Münster, Münster, Germany 

Patient Advocate – Mrs Collette Thain MBE
PBC Foundation, Edinburgh, UK

This touchPODCAST is for HCPs outside of the UK and USA only.

This activity is funded by an independent medical education grant from GlaxoSmithKline Research & Development Ltd. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC^® accredited provider.

For further information visit our website: https://touchdermatologyime.org/mdt-cholestatic-pruritus-in-patients-with-pbc/

touchMDT – Symptom assessment and monitoring in clinical practice – Discussion 2 - touchDERMATOLOGY

touchMDT for touchDERMATOLOGY

Listen to experts Ms Michelle Clayton, Prof. Sonja Ständer and Prof. Gideon Hirschfield discuss the importance of assessing for cholestatic pruritus in patients with primary biliary cholangitis (PBC) and review the tools used in clinical practice.

The multidisciplinary team:

Nurse – Ms Michelle Clayton
St James’ University Hospital, Leeds, UK

Dermatologist – Prof. Sonja Ständer
University of Münster, Münster, Germany

Hepatologist – Prof. Gideon Hirschfield
University of Toronto, Toronto, Canada

This touchPODCAST is for HCPs outside of the UK and USA only.

This activity is funded by an independent medical education grant from GlaxoSmithKline Research & Development Ltd. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC^® accredited provider.

For further information visit our website: https://touchdermatologyime.org/mdt-cholestatic-pruritus-in-patients-with-pbc/

touchMDT – A comprehensive approach to symptom care in PBC – Discussion 3 - touchDERMATOLOGY

touchMDT for touchDERMATOLOGY

Listen to experts Prof. Sonja Ständer, Ms Michelle Clayton, Prof. Gideon Hirschfield and patient advocate, Mrs Collette Thain MBE, discuss individualizing management strategies for patients with cholestatic pruritus and primary biliary cholangitis (PBC), and the importance of patient education and counselling.

The multidisciplinary team and patient advocate:

Dermatologist – Prof. Sonja Ständer
University of Münster, Münster, Germany

Nurse – Ms Michelle Clayton
St James’ University Hospital, Leeds, UK

Hepatologist – Prof. Gideon Hirschfield
University of Toronto, Toronto, Canada 

Patient Advocate – Mrs Collette Thain MBE
PBC Foundation, Edinburgh, UK

This touchPODCAST is for HCPs outside of the UK and USA only.

This activity is funded by an independent medical education grant from GlaxoSmithKline Research & Development Ltd. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC^® accredited provider.

For further information visit our website: https://touchdermatologyime.org/mdt-cholestatic-pruritus-in-patients-with-pbc/

touchMDT – A comprehensive approach to symptom care in PBC – Discussion 3 - touchIMMUNOLOGY

touchMDT for touchIMMUNOLOGY

Listen to experts Prof. Sonja Ständer, Ms Michelle Clayton, Prof. Gideon Hirschfield and patient advocate, Mrs Collette Thain MBE, discuss individualizing management strategies for patients with cholestatic pruritus and primary biliary cholangitis (PBC), and the importance of patient education and counselling.

The multidisciplinary team and patient advocate:

Dermatologist – Prof. Sonja Ständer
University of Münster, Münster, Germany

Nurse – Ms Michelle Clayton
St James’ University Hospital, Leeds, UK

Hepatologist – Prof. Gideon Hirschfield
University of Toronto, Toronto, Canada 

Patient Advocate – Mrs Collette Thain MBE
PBC Foundation, Edinburgh, UK

This touchPODCAST is for HCPs outside of the UK and USA only.

This activity is funded by an independent medical education grant from GlaxoSmithKline Research & Development Ltd. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC^® accredited provider.

For further information visit our website: https://touchimmunologyime.org/mdt-cholestatic-pruritus-in-patients-with-pbc/

touchMDT – Symptom assessment and monitoring in clinical practice – Discussion 2 - touchIMMUNOLOGY

touchMDT for touchIMMUNOLOGY

Listen to experts Ms Michelle Clayton, Prof. Sonja Ständer and Prof. Gideon Hirschfield discuss the importance of assessing for cholestatic pruritus in patients with primary biliary cholangitis (PBC) and review the tools used in clinical practice.

The multidisciplinary team:

Nurse – Ms Michelle Clayton
St James’ University Hospital, Leeds, UK

Dermatologist – Prof. Sonja Ständer
University of Münster, Münster, Germany

Hepatologist – Prof. Gideon Hirschfield
University of Toronto, Toronto, Canada

This touchPODCAST is for HCPs outside of the UK and USA only.

This activity is funded by an independent medical education grant from GlaxoSmithKline Research & Development Ltd. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC^® accredited provider.

For further information visit our website: https://touchimmunologyime.org/mdt-cholestatic-pruritus-in-patients-with-pbc/

touchMDT – Pruritus in PBC and me: The patient experience – Discussion 1 - touchIMMUNOLOGY

touchMDT for touchIMMUNOLOGY

Pruritus in PBC and me: The patient experience

Listen to experts Prof. Gideon Hirschfield and Prof. Sonja Ständer, plus patient advocate Mrs Collette Thain MBE, explore the burden of cholestatic pruritus in patients with primary biliary cholangitis (PBC).

The multidisciplinary team and patient advocate:

Hepatologist – Prof. Gideon Hirschfield
University of Toronto, Toronto, Canada

Dermatologist – Prof. Sonja Ständer
University of Münster, Münster, Germany 

Patient Advocate – Mrs Collette Thain MBE
PBC Foundation, Edinburgh, UK

This touchPODCAST is for HCPs outside of the UK and USA only.

This activity is funded by an independent medical education grant from GlaxoSmithKline Research & Development Ltd. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC^® accredited provider.

For further information visit our website: https://touchimmunologyime.org/mdt-cholestatic-pruritus-in-patients-with-pbc/

Perspectives on EGFR-mutant and wildtype NSCLC: Tailoring treatment advances in late-stage disease - touchRESPIRATORY

touchCLINICAL PERSPECTIVES for touchRESPIRATORY

Join Dr Helena Yu, course director, as she discusses the unmet needs and research opportunities in metastatic EGFR-mutant and wildtype NSCLC. By exploring key clinical trial data alongside real-world patient cases, healthcare providers will gain valuable insights into how to effectively implement these findings in clinical practice. In addition, the clinical experts highlight the critical role of biomarker testing in NSCLC for personalizing treatment plans and discuss the importance of patient support in navigating the NSCLC treatment journey.

Course director

Dr Helena Yu, Memorial Sloan Kettering Cancer Center New York, NY, USA

 

The clinical experts

Dr Aaron Lisberg, University of California Los Angeles (UCLA), Los Angeles, CA, USA

Dr Antonio Passaro, European Institute of Oncology, Milan, Italy

Dr Sara Pilotto, University of Verona, Verona, Italy

Ms Jackie Fenemore, Christie NHS Foundation Trust, Manchester, UK

Prof. Egbert Smit, Leiden University Medical Center, Leiden, The Netherlands and Netherlands Cancer Institute, Amsterdam, The Netherlands

 

Modules

Module 1: EGFR-mutant NSCLC: Navigating the horizon in EGFR-mutant NSCLC (timestamp: 0:00 - 32:33)

Module 2: EGFR-wildtype NSCLC: Advances in the treatment landscape (timestamp: 32:34 - 01:06:10)

Module 3: Bringing it together (timestamp: 01:06:10 - 01:43:40)

 

This touchPODCAST is for HCPs only.

This activity is funded by an educational grant from AstraZeneca Ltd. 

This medical education is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.

 

For further information visit our website:  

https://touchoncologyime.org/egfr-and-wildtype-late-stage-nsclc-management/

For further information visit our website:  https://touchrespiratoryime.org/egfr-and-wildtype-late-stage-nsclc-management